42 related articles for article (PubMed ID: 8761299)
1. A new member of the Eph family of receptors that lacks protein tyrosine kinase activity.
Gurniak CB; Berg LJ
Oncogene; 1996 Aug; 13(4):777-86. PubMed ID: 8761299
[TBL] [Abstract][Full Text] [Related]
2. Potential role of the Eph/ephrin system in colorectal cancer: emerging druggable molecular targets.
Scarini JF; Gonçalves MWA; de Lima-Souza RA; Lavareze L; de Carvalho Kimura T; Yang CC; Altemani A; Mariano FV; Soares HP; Fillmore GC; Egal ESA
Front Oncol; 2024; 14():1275330. PubMed ID: 38651144
[TBL] [Abstract][Full Text] [Related]
3. The Clinical Relevance of the EPH/Ephrin Signaling Pathway in Pediatric Solid and Hematologic Malignancies.
Chatzikalil E; Stergiou IE; Papadakos SP; Konstantinidis I; Theocharis S
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612645
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of EphB6 and EphrinB2 controls soma spacing of cortical neurons in a mutual inhibitory way.
He CH; Song NN; Xie PX; Wang YB; Chen JY; Huang Y; Hu L; Li Z; Su JH; Zhang XQ; Zhang L; Ding YQ
Cell Death Dis; 2023 May; 14(5):309. PubMed ID: 37149633
[TBL] [Abstract][Full Text] [Related]
5. The EphB6 Receptor: Kinase-Dead but Very Much Alive.
Strozen TG; Sharpe JC; Harris ED; Uppalapati M; Toosi BM
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360976
[TBL] [Abstract][Full Text] [Related]
6. Emerging Roles for Eph Receptors and Ephrin Ligands in Immunity.
Darling TK; Lamb TJ
Front Immunol; 2019; 10():1473. PubMed ID: 31333644
[TBL] [Abstract][Full Text] [Related]
7. EPHB6 mutation induces cell adhesion-mediated paclitaxel resistance via EPHA2 and CDH11 expression.
Yoon S; Choi JH; Kim SJ; Lee EJ; Shah M; Choi S; Woo HG
Exp Mol Med; 2019 Jun; 51(6):1-12. PubMed ID: 31160603
[TBL] [Abstract][Full Text] [Related]
8. The EphB6 receptor is overexpressed in pediatric T cell acute lymphoblastic leukemia and increases its sensitivity to doxorubicin treatment.
El Zawily A; McEwen E; Toosi B; Vizeacoumar FS; Freywald T; Vizeacoumar FJ; Freywald A
Sci Rep; 2017 Nov; 7(1):14767. PubMed ID: 29116180
[TBL] [Abstract][Full Text] [Related]
9. Loss of the EPH receptor B6 contributes to colorectal cancer metastasis.
Mateo-Lozano S; Bazzocco S; Rodrigues P; Mazzolini R; Andretta E; Dopeso H; Fernández Y; Del Llano E; Bilic J; Suárez-López L; Macaya I; Cartón-García F; Nieto R; Jimenez-Flores LM; de Marcondes PG; Nuñez Y; Afonso E; Cacci K; Hernández-Losa J; Landolfi S; Abasolo I; Ramón Y Cajal S; Mariadason JM; Schwartz S; Matsui T; Arango D
Sci Rep; 2017 Mar; 7():43702. PubMed ID: 28262839
[TBL] [Abstract][Full Text] [Related]
10. The intrinsically kinase-inactive EPHB6 receptor predisposes cancer cells to DR5-induced apoptosis by promoting mitochondrial fragmentation.
El Zawily AM; Toosi BM; Freywald T; Indukuri VV; Vizeacoumar FJ; Leary SC; Freywald A
Oncotarget; 2016 Nov; 7(47):77865-77877. PubMed ID: 27788485
[TBL] [Abstract][Full Text] [Related]
11. Targeting synthetic lethality between the SRC kinase and the EPHB6 receptor may benefit cancer treatment.
Paul JM; Toosi B; Vizeacoumar FS; Bhanumathy KK; Li Y; Gerger C; El Zawily A; Freywald T; Anderson DH; Mousseau D; Kanthan R; Zhang Z; Vizeacoumar FJ; Freywald A
Oncotarget; 2016 Aug; 7(31):50027-50042. PubMed ID: 27418135
[TBL] [Abstract][Full Text] [Related]
12. Expression of the Receptor Tyrosine Kinase EphB2 on Dendritic Cells Is Modulated by Toll-Like Receptor Ligation but Is Not Required for T Cell Activation.
Mimche PN; Brady LM; Keeton S; Fenne DS; King TP; Quicke KM; Hudson LE; Lamb TJ
PLoS One; 2015; 10(9):e0138835. PubMed ID: 26407069
[TBL] [Abstract][Full Text] [Related]
13. Roles of EphA2 in Development and Disease.
Park JE; Son AI; Zhou R
Genes (Basel); 2013 Jul; 4(3):334-57. PubMed ID: 24705208
[TBL] [Abstract][Full Text] [Related]
14. A robust methodology to subclassify pseudokinases based on their nucleotide-binding properties.
Murphy JM; Zhang Q; Young SN; Reese ML; Bailey FP; Eyers PA; Ungureanu D; Hammaren H; Silvennoinen O; Varghese LN; Chen K; Tripaydonis A; Jura N; Fukuda K; Qin J; Nimchuk Z; Mudgett MB; Elowe S; Gee CL; Liu L; Daly RJ; Manning G; Babon JJ; Lucet IS
Biochem J; 2014 Jan; 457(2):323-34. PubMed ID: 24107129
[TBL] [Abstract][Full Text] [Related]
15. Receptor tyrosine kinases with intracellular pseudokinase domains.
Mendrola JM; Shi F; Park JH; Lemmon MA
Biochem Soc Trans; 2013 Aug; 41(4):1029-36. PubMed ID: 23863174
[TBL] [Abstract][Full Text] [Related]
16. EphB-ephrin-B2 interactions are required for thymus migration during organogenesis.
Foster KE; Gordon J; Cardenas K; Veiga-Fernandes H; Makinen T; Grigorieva E; Wilkinson DG; Blackburn CC; Richie E; Manley NR; Adams RH; Kioussis D; Coles MC
Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13414-9. PubMed ID: 20616004
[TBL] [Abstract][Full Text] [Related]
17. Kinase-dependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis.
Taddei ML; Parri M; Angelucci A; Onnis B; Bianchini F; Giannoni E; Raugei G; Calorini L; Rucci N; Teti A; Bologna M; Chiarugi P
Am J Pathol; 2009 Apr; 174(4):1492-503. PubMed ID: 19264906
[TBL] [Abstract][Full Text] [Related]
18. Structure of the pseudokinase VRK3 reveals a degraded catalytic site, a highly conserved kinase fold, and a putative regulatory binding site.
Scheeff ED; Eswaran J; Bunkoczi G; Knapp S; Manning G
Structure; 2009 Jan; 17(1):128-38. PubMed ID: 19141289
[TBL] [Abstract][Full Text] [Related]
19. EphB6-null mutation results in compromised T cell function.
Luo H; Yu G; Tremblay J; Wu J
J Clin Invest; 2004 Dec; 114(12):1762-73. PubMed ID: 15599401
[TBL] [Abstract][Full Text] [Related]
20. Central role of the threonine residue within the p+1 loop of receptor tyrosine kinase in STAT3 constitutive phosphorylation in metastatic cancer cells.
Yuan ZL; Guan YJ; Wang L; Wei W; Kane AB; Chin YE
Mol Cell Biol; 2004 Nov; 24(21):9390-400. PubMed ID: 15485908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
